NordicCan A/S: Financial statements 2020
CVR: 37633925
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NordicCan A/S (CVR 37633925) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK -1,987,000 compared with DKK -52,000 the year before. Equity in the 2020 report amounted to DKK -175,000.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -1,987,000
- Equity
- DKK -175,000
- Total Assets
- DKK 8,918,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 0 | -2M | -175K | - |
| 2019 | - | 84K | -52K | 1.8M | - |
| 2018 | - | -8.3M | -7.7M | 1.9M | 2 |
| 2017 | - | -6K | -7K | 481K | - |
Official annual report
How creditworthy is NordicCan A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
On September 3, 2020, the company changed its name from MedCan Pharma A/S to NordicCan A/S.
As of August 1, 2020, Peter Halling has joined the board of directors of NordicCan A/S.
As of August 1, 2020, Søren Birn has left the board of directors of NordicCan A/S.
As of August 1, 2020, Peter Halling is registered as adm. dir. of NordicCan A/S.
As of August 1, 2020, Søren Birn has stepped down as adm. dir. of NordicCan A/S.
NordicCan A/S has published its annual report for 2019. Gross profit came to DKK 84,000, and the net result was DKK -52,000.
As of February 6, 2020, Søren Birn has joined the board of directors of NordicCan A/S.
As of February 6, 2020, Søren Birn is registered as adm. dir. of NordicCan A/S.
As of February 6, 2020, Michael Henrik Thomsen is registered as chairman of NordicCan A/S.
As of February 6, 2020, Morten la Cour Pedersen has stepped down as adm. dir. of NordicCan A/S.
About NordicCan A/S
NordicCan A/S was a Danish company of the type Aktieselskab based in Vejle, founded in 2016. The company has been dissolved on 24 March 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MedCan Pharma A/S. The company has 22 employees (2018). In 2021, the company reported a net result of DKK -4,058,000 compared with DKK -1,987,000 the year before. Equity in the 2021 report amounted to DKK 5,767,000.